Aphria, Wayland face challenge over German marijuana cultivation contracts
Germany's efforts to get domestic cultivation up and running took another step forward today, as the German Federal Institute…
News April 17
Latest In: Aphria
Aphria reports CA$108 million loss on lower marijuana sales
Despite a sharp increase in revenue, Ontario-based Aphria's third-quarter 2018 profit of 12.9 million Canadian dollars ($9.6 million)…
News April 15
Aphria, Aurora and Demecan selected for German medical cannabis cultivation
Three companies were chosen to cultivate medical marijuana in Germany - the result of a long-delayed application process…
News April 4
Men hold 93% of Canadian cannabis boardroom positions
Two dozen of the leading cannabis companies in Canada collectively employ only 11 women on their boards, and…
News March 24
Canadian medical cannabis exports tripled last year, as race for European market position intensifies
Exports of medical cannabis from Canada soared last year as the country’s biggest licensed cannabis companies continued to…
News March 21
Aphria’s flagship CA$190 million cannabis greenhouse is fully licensed
Aphria’s primary cannabis facility in Leamington, Ontario, is now fully authorized by Health Canada to begin cultivation, paving…
News March 6
Mold, labeling errors cause rash of cannabis recalls in Canada
A number of cannabis recalls over labeling errors and mold is a sign that the federal health department’s…
News March 1
Major Canadian pension fund loads up on cannabis stocks
One of Canada’s biggest pension managers increased its stake in Canopy Growth and took positions in three more…
News February 22
Report: Largest marijuana firms already control most of Canada’s regulated adult-use market
Canada’s largest licensed cannabis producers already have a stranglehold on the country’s regulated recreational market just four months…
News February 20Featured
1
Latest Sponsored
